作者:
Aya,Shiba-Ishii [1]
;
Ted W,Johnson [2]
;
Ibiayi,Dagogo-Jack [3]
;
Mari,Mino-Kenudson [4]
;
Theodore R,Johnson [2]
;
Ping,Wei [2]
;
Scott L,Weinrich [2]
;
Michele A,McTigue [2]
;
Makeba A,Walcott [1]
;
Linh,Nguyen-Phuong [1]
;
Kristin,Dionne [1]
;
Adam,Acker [1]
;
Lesli A,Kiedrowski [5]
;
Andrew,Do [3]
;
Jennifer L,Peterson [3]
;
Jaimie L,Barth [6]
;
Beow Y,Yeap [3]
;
Justin F,Gainor [3]
;
Jessica J,Lin [7]
;
Satoshi,Yoda [8]
;
Aaron N,Hata [9]
作者单位:
Massachusetts General Hospital Cancer Center, Charlestown, MA, USA.
[1]
Pfizer Worldwide Research and Development, La Jolla, CA, USA.
[2]
Massachusetts General Hospital Cancer Center, Charlestown, MA, USA.;Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
[3]
Massachusetts General Hospital Cancer Center, Charlestown, MA, USA.;Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.;Department of Pathology, Harvard Medical School, Boston, MA, USA.
[4]
Guardant Health, Redwood City, CA, USA.
[5]
Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
[6]
Massachusetts General Hospital Cancer Center, Charlestown, MA, USA. jjlin1@partners.org.;Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. jjlin1@partners.org.
[7]
Massachusetts General Hospital Cancer Center, Charlestown, MA, USA. syoda@mgh.harvard.edu.;Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. syoda@mgh.harvard.edu.
[8]
Massachusetts General Hospital Cancer Center, Charlestown, MA, USA. ahata@mgh.harvard.edu.;Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. ahata@mgh.harvard.edu.
[9]
DOI
10.1038/s43018-022-00399-6
PMID
35726063
发布时间
2024-09-08